LHLaboratory Corp. Of America Holdings
LH
Laboratory Corp. Of America Holdings2,118
Mkt Cap
$23.43BVolume
5,132.0052W High
$293.7252W Low
$209.38PE Ratio
27.76LH Fundamentals
Price
$282.63Prev Close
$278.11Open
$277.5150D MA
$263.78Beta
0.57Avg. Volume
801,784.95EPS (Annual)
$8.84P/B
2.70Rev/Employee
$185,841.43$25,123.01
Earnings Recap
• Reported GAAP EPS of $2.00 up 16.28% YoY • Reported revenue of $3.52B up 5.60% YoY • Labcorp expects Full-Year 2026 Enterprise Revenue of $14.61B to $14.79B, a midpoint growth of 5.4%. Adjusted EPS is guided to $17.55 to $18.25, with Free Cash Flow of $1.24B to $1.36B.
Bullish
Labcorp is expanding with a new Central Laboratory facility and 13 new partnerships. The company also launched over 130 innovative tests, including an FDA-cleared Alzheimer's blood test, driving strong 2025 revenue and adjusted EPS.
Bearish
Labcorp experienced decreased Free Cash Flow in Q4 2025 due to working capital timing. The company also faces operational risks from personnel costs and external threats from regulatory changes and increased competition.